| Name | Northridge Care Center |
|---|---|
| Location | 3612 Baker Blvd, Baker, Louisiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 132 |
| Occupancy Rate | 65.53% |
| Medicare ID (CCN) | 195561 |
| Legal Business Name | Northridge Care Center Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1154081263 |
| Organization Name | RIVER OAKS NURSING & REHABILITATION CENTER LLC |
| Address | 3612 Baker Blvd, Baker, LA 70714 |
| Phone Number | 225-778-0573 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.
Scientists now have a better understanding of a perplexing gene that is associated with susceptibility for a wide spectrum of severely debilitating mental illnesses. Two independent research studies published by Cell Press in the September 24th issue of the journal Neuron provide fascinating insight into the molecular mechanisms that link disrupted-in-schizophrenia 1 (DISC1) with the proper development and migration of neurons in the hippocampus, a brain area involved in learning and memory and associated with the pathology of schizophrenia.
Researchers at New York University's Courant Institute of Mathematical Sciences have developed a new algorithm that can lead to more accurate detection of cancer genes than previous versions.
Eisai announced today that results from the global Phase III clinical study "EMBRACE" will be published online in The Lancet.
Healthcare workers' use of disposable gowns and gloves upon entering all patient rooms on an intensive care unit (ICU), versus only in rooms on standard isolation protocol, helped reduce patient acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by approximately 40 percent, according to new research co-led by the University of Maryland School of Medicine and the Yale New Haven Health System Center for Healthcare Solutions.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.
Scientists now have a better understanding of a perplexing gene that is associated with susceptibility for a wide spectrum of severely debilitating mental illnesses. Two independent research studies published by Cell Press in the September 24th issue of the journal Neuron provide fascinating insight into the molecular mechanisms that link disrupted-in-schizophrenia 1 (DISC1) with the proper development and migration of neurons in the hippocampus, a brain area involved in learning and memory and associated with the pathology of schizophrenia.
Researchers at New York University's Courant Institute of Mathematical Sciences have developed a new algorithm that can lead to more accurate detection of cancer genes than previous versions.
Eisai announced today that results from the global Phase III clinical study "EMBRACE" will be published online in The Lancet.
Healthcare workers' use of disposable gowns and gloves upon entering all patient rooms on an intensive care unit (ICU), versus only in rooms on standard isolation protocol, helped reduce patient acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by approximately 40 percent, according to new research co-led by the University of Maryland School of Medicine and the Yale New Haven Health System Center for Healthcare Solutions.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7296 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.04 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.09 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 46.1 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.5 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.1 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.03 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.26 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 26.61 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 48.33 | 83.88 |